CentriLogic Secures Strategic Equity Investment from TriSpan Opportunities Fund and Long Point Capital
TORONTO, June 13, 2018 (GLOBE NEWSWIRE) -- CentriLogic, a
global provider of managed IT solutions, announced today it
has secured a significant equity investment from TriSpan
Opportunities Fund and Long Point Capital. The investment
will be used to support CentriLogic’s strategy of delivering
end-to-end managed hosting, private network, and application
management solutions to mid and large-sized enterprises
globally. Financial terms of the investment were not
“We are experiencing increased demand from IT decision makers who are looking for full-stack application management and infrastructure solutions. We continue to push aggressively into the application layer to drive the best possible outcomes for our clients,” says Robert Offley, President and CEO of CentriLogic. “We have developed a comprehensive platform of solutions designed to fulfill this demand, and this investment will better position us to accelerate our growth and enable us to achieve continued success in the global managed IT solutions market.”
CentriLogic was founded in 2007 and has a proven track record of delivering to clients adaptable and dependable IT solutions that support their unique application and workload requirements. The company has consistently been recognized in PROFIT magazine’s annual list of Canada’s Fastest-Growing Companies, and was recently named a “Major Player” in IDC’s MarketScape Report on Canadian Infrastructure as a Service Providers.
“CentriLogic is well-positioned for long-term growth given its breadth of services and solutions, its strong leadership team, and impressive roster of existing clients,” says Elan Schultz, Founding Partner of TriSpan. Eric Von Stroh, Managing Director of Long Point, adds, “We are excited to partner with the CentriLogic team to enable them to continue to enhance the service offering both organically and through acquisitions.”
CentriLogic is a global provider of managed IT solutions. With a comprehensive portfolio of IT infrastructure, private connectivity, and application services, CentriLogic works with clients to develop adaptable and dependable IT solutions that enable them to achieve positive business outcomes. The company’s dedication to a client-centric philosophy has earned it the trust of some of the world’s most innovative companies and visionaries. With regional headquarters in Canada, USA, and the United Kingdom, CentriLogic delivers solutions to clients worldwide.
For more information, please visit www.centrilogic.com.
About TriSpan Opportunities Fund and Long Point Capital:
TriSpan, with offices in New York and London, is an independent and management controlled private equity platform, backed by leading family investment groups. TriSpan Opportunities Fund offers deal-by-deal co-investment opportunities on a formulaic basis with attractive overall terms. Its senior partners have built a solid track record of $4bn committed in over 110 deals across multiple strategies, geographies and sectors.
Long Point Capital, with offices in New York and Michigan, invests in outstanding founder, family, and management-owned companies with highly capable management teams and strong growth prospects. Long Point is currently investing from Long Point Capital Fund III with $240 million of capital in partnership with TriSpan and a leading group of limited partners who will provide additional capital where required.
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
- Larotrectinib Delivers 81% Overall Response Rate in an Expanded Dataset of 109 TRK Fusion Cancer Patients Across Ages and Tumor Types
- Mirati Therapeutics Announces Updated Data From Ongoing Clinical Trial Of Single Agent Sitravatinib At The 2018 ESMO Congress
- DGAP-News: MorphoSys's Licensing Partner GSK has Reported Data on GSK3196165 from Phase 2 Study in Rheumatoid Arthritis to be Presented at the ACR Conference
- Elbit Systems Announces the Results of its Extraordinary and Annual General Meeting of Shareholders Held on October 18, 2018
- Varian Forms FlashForward Consortium to Study Ultra-high Dose Rate Cancer Treatments with Protons
- Varian Introduces New ProBeam 360° Proton Therapy System